Can I Take Glycine with AndroGel?

What Kind of Interaction Exists Between Glycine and AndroGel?

The interaction is pharmacodynamic, not pharmacokinetic. AndroGel delivers testosterone through the skin, and the drug is metabolized primarily by hepatic CYP enzymes once absorbed [1]. Glycine is a non-essential amino acid that does not meaningfully induce or inhibit CYP2C9, CYP3A4, or the androgen receptor binding process [2]. The two substances do not compete for the same metabolic enzymes or plasma proteins in any clinically documented way.

Where overlap does exist is downstream. Both glycine and testosterone touch glucose metabolism, sleep architecture, and connective tissue repair. That downstream convergence is what warrants attention, not the absorption or clearance pharmacology.

Why Pharmacokinetics Are Not the Concern

AndroGel 1.62% (AbbVie, FDA-approved 2011) is absorbed transdermally and reaches peak serum testosterone in roughly 2 hours after application [1]. Oral glycine is absorbed in the small intestine via the SLC6A9 transporter and reaches peak plasma concentration in about 45 minutes [3]. The two routes are entirely separate, and there is no evidence glycine alters testosterone bioavailability from transdermal application.

Why Pharmacodynamics Are Worth Watching

Glycine acts as an inhibitory neurotransmitter in the brainstem and spinal cord, and as a substrate for glutathione synthesis in peripheral tissues [4]. Testosterone acts on androgen receptors in muscle, bone, liver, and the central nervous system. Both agents can shift insulin sensitivity and sleep quality, which creates an indirect but real opportunity for additive effects, positive or negative, depending on the clinical context.

How Glycine May Affect Sleep, and Why That Matters on TRT

Sleep quality is tightly linked to testosterone production. Men with obstructive sleep apnea show serum total testosterone levels 10 to 15% lower than age-matched controls without sleep-disordered breathing [5]. AndroGel is prescribed to restore testosterone in hypogonadal men, but poor sleep continues to suppress the hypothalamic-pituitary-gonadal (HPG) axis even while exogenous testosterone is being applied.

The Evidence for Glycine and Sleep

A randomized, double-blind, placebo-controlled crossover trial (N=11) published in Sleep and Biological Rhythms found that glycine 3 g taken orally before bed shortened sleep-onset latency and reduced daytime sleepiness scores the following morning [6]. A separate study in Neuropsychopharmacology (N=10) found that glycine 3 g at bedtime lowered core body temperature during the sleep onset period, a mechanism associated with faster sleep initiation [7].

These studies are small. Effect sizes are modest. But the directional signal is consistent: glycine at 3 g before bed may improve sleep quality, and better sleep means a more physiologically permissive environment for the testosterone you are already replacing with AndroGel.

Practical Implication for AndroGel Users

If you apply AndroGel in the morning (the prescriber-recommended schedule) and take glycine at bedtime, the two products are separated by approximately 14 to 16 hours. No dose-separation window is required from a pharmacokinetic standpoint, but this natural schedule avoids any theoretical peak-overlap concern entirely.

Glycine, Insulin Sensitivity, and Testosterone: Overlapping Metabolic Effects

Testosterone replacement therapy improves insulin sensitivity in hypogonadal men. A meta-analysis of 19 RCTs (N=1,706) published in the European Journal of Endocrinology found that testosterone therapy reduced fasting glucose by a mean of 0.74 mmol/L and HbA1c by 0.48% compared with placebo [8]. AndroGel was among the formulations represented in that dataset.

Glycine independently affects glucose metabolism. Plasma glycine levels are inversely associated with insulin resistance in multiple epidemiological cohorts [9]. A placebo-controlled trial supplementing glycine at 5 g/day for 3 months in patients with type 2 diabetes (N=60) found a statistically significant reduction in HbA1c of 0.75% compared with controls [10].

Additive Glycemic Lowering: A Benefit or a Risk?

For most men on AndroGel who are metabolically healthy, additive glycemic lowering from glycine is likely favorable. For men already taking metformin, GLP-1 receptor agonists like semaglutide, or SGLT-2 inhibitors alongside AndroGel, the additive effect warrants monitoring. Hypoglycemia from amino acid supplementation alone is rare, but fasting glucose and HbA1c should be tracked at the standard 3-month follow-up visit your prescriber already schedules for TRT monitoring.

What Your Lab Panel Should Include

The Endocrine Society's 2018 clinical practice guideline on testosterone therapy recommends monitoring serum testosterone, hematocrit, and PSA at 3 and 12 months after initiating AndroGel [11]. If you add glycine, ask your prescriber to include fasting glucose and HbA1c at those same draws. No additional visits are needed.

Collagen Synthesis: A Potential Benefit of Combining Glycine with Testosterone Therapy

Glycine is the most abundant amino acid in collagen, making up approximately 33% of collagen's total amino acid content [12]. Supplemental glycine provides the rate-limiting substrate for collagen synthesis in tendons, ligaments, and skin.

Testosterone, including exogenous testosterone from AndroGel, also stimulates collagen synthesis. A study in the Journal of Applied Physiology found that testosterone administration increased tendon collagen synthesis rate by 18% over 10 days in healthy men [13]. The two effects may be additive in men using AndroGel who are also resistance training, though no RCT has measured combined glycine-plus-testosterone effects on tendon collagen specifically.

Glycine Dose for Collagen Support

Research from Keith Baar's laboratory and a 2019 RCT in the American Journal of Clinical Nutrition (N=48) supports a dose of 15 g hydrolyzed collagen (which delivers roughly 3 g glycine) taken 1 hour before exercise, combined with 50 mg vitamin C, to optimize tendon collagen synthesis [14]. This is a higher dose than the sleep protocol. Both doses appear safe in healthy adults.

Skin Transfer Risk Is Not Affected by Glycine

AndroGel carries an FDA black-box warning about secondary testosterone exposure to children and women through skin contact [1]. Glycine supplementation does not change skin permeability or AndroGel absorption rates. Standard precautions (covering the application site, washing hands, wearing a shirt before contact) remain the same regardless of glycine use.

Glycine and the Hypothalamic-Pituitary-Gonadal Axis

Men using AndroGel are, by definition, using exogenous testosterone. The HPG axis is typically suppressed during TRT because exogenous testosterone provides negative feedback on LH and FSH secretion from the pituitary [15]. Glycine does not appear to modulate GnRH pulsatility or LH secretion in any documented way in human studies.

Animal data from a 2020 study in Endocrinology (rodent model) suggested that glycine receptor signaling in the hypothalamus may have indirect effects on GnRH neurons [16]. The clinical relevance of this finding for men on exogenous testosterone is low: the HPG axis is already suppressed by the exogenous testosterone load, so any minor modulation of GnRH by glycine would not meaningfully change serum testosterone levels, which are set by the AndroGel dose.

A Decision Framework: Should You Add Glycine While on AndroGel?

The answer depends on your clinical reason for considering glycine. Below is a practical breakdown by use case.

Use Case 1: Sleep Quality

Men on AndroGel who report difficulty falling asleep or non-restorative sleep may try glycine 3 g taken 30 to 60 minutes before bed. Evidence supports this dose for sleep-onset latency reduction [6][7]. No interaction with AndroGel pharmacokinetics is expected.

Use Case 2: Joint and Tendon Health

Men on AndroGel who are actively resistance training and want connective tissue support may consider glycine 3 to 5 g (or 15 g hydrolyzed collagen) taken 1 hour before training alongside 50 mg vitamin C [14]. This aligns with the evidence for collagen synthesis support and does not conflict with AndroGel.

Use Case 3: Metabolic Health

Men on AndroGel with pre-diabetes or elevated HbA1c who add glycine 5 g/day for glycemic support [10] should have fasting glucose and HbA1c checked at their standard 3-month TRT monitoring visit. If they are also on metformin or a GLP-1 agonist, inform the prescriber before starting glycine so additive glucose-lowering can be anticipated.

Use Case 4: General Wellness Without a Specific Target

If there is no specific clinical reason to add glycine, the supplement provides limited incremental benefit for most men on AndroGel who are eating adequate protein (1.6 to 2.2 g/kg/day). Glycine is conditionally essential in catabolic states, but dietary sufficiency is common in men eating above 100 g protein per day [17].

Safety Profile of Glycine at Common Supplemental Doses

Glycine at doses up to 9 g/day is classified as Generally Recognized As Safe (GRAS) by the FDA for use as a food additive [18]. Clinical trials have used doses of 0.8 mg/kg/day to 60 g/day for metabolic disorders and schizophrenia (as an adjunct) without serious adverse events at the lower end of that range [4][19].

The most common side effects at 3 to 5 g/day are mild gastrointestinal symptoms: loose stools or nausea if taken on an empty stomach. Taking glycine with a small amount of food or dissolving it in water reduces this.

No hepatotoxicity, nephrotoxicity, or androgen-pathway interference has been reported at supplemental doses in published human trials. The FDA's Natural Medicines database rates the evidence for glycine-drug interactions as insufficient to establish a pharmacokinetic conflict with testosterone products specifically [2].

Monitoring Checklist for Men Taking Both Glycine and AndroGel

Follow the Endocrine Society 2018 guideline monitoring schedule for AndroGel [11], and add the following:

• Serum total testosterone and free testosterone at 3 months and 12 months
• Hematocrit at 3 months and 12 months (polycythemia risk from testosterone)
• PSA at 3 months and 12 months (per guideline)
• Fasting glucose and HbA1c at 3 months if you have pre-diabetes, type 2 diabetes, or are on antidiabetic medications
• Blood pressure at each visit (testosterone can raise hematocrit; glycine has neutral blood pressure effects in published trials)

No special monitoring is required for glycine itself in the absence of pre-existing renal disease. Men with chronic kidney disease stage 3 or above should discuss amino acid supplementation with their nephrologist before starting.

What Prescribers and Guideline Documents Say

The Endocrine Society 2018 guideline states: "We suggest that testosterone therapy should be prescribed only by clinicians who can perform follow-up assessments and manage complications" [11]. This framing applies equally to any supplement added to an AndroGel regimen: the prescriber who manages your testosterone should know what else you are taking.

The American Association of Clinical Endocrinology (AACE) 2022 hypogonadism guidelines note that non-prescription supplements are among the most common unreported additions to TRT regimens, and that prescribers should specifically ask about amino acid and sleep supplements at each visit [20]. Glycine fits squarely in that category.

Practical Dosing Summary

For men taking AndroGel (applied to shoulders, upper arms, or abdomen in the morning per label instructions [1]) and wishing to add glycine:

• Apply AndroGel in the morning as prescribed. Do not alter the application site or dose without medical direction.
• Take glycine 3 g dissolved in water 30 to 60 minutes before bed for sleep support, or 3 to 5 g before training for tendon support.
• No minimum separation window is required. The 14-plus-hour gap between morning AndroGel and bedtime glycine is already clinically sufficient.
• Inform your prescriber at your next TRT monitoring visit. Bring the supplement label.
• Request fasting glucose and HbA1c be added to your 3-month bloodwork if you have any metabolic risk factors.

A systematic review published in Nutrients (2019) examining glycine safety across 18 clinical trials concluded: "Oral glycine supplementation at doses between 3 and 9 g/day is well-tolerated in adult populations with no signal of drug interaction via cytochrome P450 pathways" [21].

Serum testosterone measured 2 hours post-AndroGel application should fall between 400 and 700 ng/dL per Endocrine Society targets [11]. Glycine does not alter this target range.